Advertisement
Home Tags Vaccines

Tag: Vaccines

Health insurance companies are expected to cover vaccines for the new coronavirus without charging copays

U.S. Insurers Should Not Charge Copays for COVID-19 Vaccine

Government has been in discussions with insurers about covering COVID-19 vaccination at no cost to patients
About 6.1 percent of parents are hesitant about routine childhood vaccines

More Than One in Four Parents Hesitant About Flu Vaccine

Seventy and 26 percent strongly agree that routine and flu vaccines are effective, respectively
Oral polio vaccines might provide temporary protection against the new coronavirus while scientists try to develop a vaccine to fight COVID-19 infection

Oral Polio Vaccines Might Protect Against New Coronavirus

Since poliovirus and coronavirus are positive-strand RNA viruses, they may induce common innate immunity mechanisms
A large clinical trial of the first U.S. COVID-19 vaccine could begin next month

First Large Clinical Trial of COVID-19 Vaccine in U.S. Could Begin in July

Trial will assess effectiveness of vaccine, include 30,000 volunteers who will receive either vaccine or placebo
A partnership that would bypass the drug industry to sell a potential vaccine against the new coronavirus has been formed by a laboratory at Imperial College London.

Partnership Would Bypass Drug Industry to Sell COVID-19 Vaccine

Vaccine could be sold without profits or licensing fees in Britain and low- and middle-income countries
Francis Collins

NIH Head Fears Some Will Bypass a COVID-19 Vaccine

Name of campaign -- 'Operation Warp Speed' -- does not mean corners will be cut on safety
According to Anthony Fauci

Fauci Says Any COVID-19 Vaccine Would Be in Plentiful Supply by 2021

Plan is to make doses of the vaccine before it is known to work, so if it does work, it can be distributed quickly
A recombinant adenovirus type-5 vectored COVID-19 vaccine is safe

Adenovirus Type-5 Vectored COVID-19 Vaccine Shows Promise

ELISA antibodies and neutralizing antibodies increased at day 14, peaked at day 28
The U.S. Department of Health and Human Services said Thursday it would provide up to $1.2 billion to AstraZeneca to develop a potential COVID-19 vaccine from a lab in Oxford

U.S. Offers $1.2 Billion to Drug Company for COVID-19 Vaccine Research

Deal will fund phase 3 clinical trial in the United States this summer with about 30,000 volunteers
There has been a decrease in child vaccination coverage in almost all milestone age cohorts during the COVID-19 pandemic

Decrease Seen in Child Vaccination Coverage During COVID-19

Up-to-date status for all recommended vaccines down to 49.7 percent among children aged 5 months